Provided by Tiger Trade Technology Pte. Ltd.

Progress

43.71
-0.6500-1.47%
Volume:96.24K
Turnover:4.24M
Market Cap:1.79B
PE:21.11
High:44.99
Open:44.19
Low:43.61
Close:44.36
52wk High:47.37
52wk Low:23.82
Shares:41.01M
Float Shares:40.11M
Volume Ratio:0.35
T/O Rate:0.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.07
EPS(LYR):1.66
ROE:18.57%
ROA:4.89%
PB:3.54
PE(LYR):26.33

Loading ...

Moleculin: Buy Rating Maintained as MIRACLE Trial Progress Offsets Dilution; McCarthy Trims Price Target After Equity Financing

TIPRANKS
·
Aug 15

Northwest Healthcare Properties Earnings Call Signals Progress

TIPRANKS
·
Aug 15

Western Forest Products Balances Progress With Tariff Pain

TIPRANKS
·
Aug 15

CAMP4 Analyst Day, Strong Cash Runway and SYNGAP1 Trial Progress Drive Upward Price-Target Revision to $8 with Buy Rating

TIPRANKS
·
Aug 15

DarkIris Inc. Updates Strategic and Operational Progress on AI Initiatives and Gaming Business

GlobeNewswire
·
Aug 15

Intellia Therapeutics: Buy Rating Reiterated as Clinical Progress and Risk Management Support Unchanged $29 Price Target

TIPRANKS
·
Aug 15

PAVmed Reports Q2 2026 Results and Operational Progress

TIPRANKS
·
Aug 14

Is Phase III Rezpegaldesleukin And Cash Runway Progress Altering The Investment Case For Nektar Therapeutics (NKTR)?

Simply Wall St.
·
Aug 14

Eikon Therapeutics Highlights Q3 2026 Oncology Pipeline Progress

TIPRANKS
·
Aug 14

Creative Media Reports Narrowed Loss, Strong Operational Progress

TIPRANKS
·
Aug 14

Atara Biotherapeutics’ Executive Turnover and Workforce Cuts Elevate Execution Risk and Threaten Strategic Progress

TIPRANKS
·
Aug 14

Osisko Gold Group Bolsters Cash, Funding and Drilling Progress in Q2 2026

TIPRANKS
·
Aug 14

SGH Updates Market on Daily Progress of On‑Market Share Buy‑Back

TIPRANKS
·
Aug 14

Global Atomic Sees Dasa Progress but Pushes Yellowcake Output to 2028

TIPRANKS
·
Aug 14

Adagio Medical Highlights VT Ablation Progress in Presentation

TIPRANKS
·
Aug 14

Satellos Reports Second Quarter 2026 Financial Results and Highlights Company Progress

GlobeNewswire
·
Aug 14

Press Release: Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform

Dow Jones
·
Aug 14

Mitchell Kapoor Reiterates Buy on MeiraGTx, Maintains $20 12-Month Price Target on Clinical Progress and Strengthened Balance Sheet

TIPRANKS
·
Aug 14

Target Making Progress in Revitalizing Topline, Morgan Stanley Says

MT Newswires Live
·
Aug 13

Phil Nadeau Reiterates Buy on Kura Oncology as Komzifti Outperforms Expectations and Pipeline Progress Strengthens Long-Term Outlook

TIPRANKS
·
Aug 13